Literature DB >> 24164862

Impact of sleep-disordered breathing on myocardial salvage and infarct size in patients with acute myocardial infarction.

Stefan Buchner1, Anna Satzl, Kurt Debl, Andrea Hetzenecker, Andreas Luchner, Oliver Husser, Okka W Hamer, Florian Poschenrieder, Claudia Fellner, Florian Zeman, Günter A J Riegger, Michael Pfeifer, Michael Arzt.   

Abstract

AIMS: Sleep-disordered breathing (SDB) may be a risk factor for expansion of infarct size early after acute myocardial infarction (MI) by exposing the heart to repetitive oxygen desaturations and increased cardiac afterload. The objective of this study was to assess the impact of SDB on myocardial salvage and infarct size within 3 months after acute MI. METHODS AND
RESULTS: Patients with acute MI and percutaneous coronary intervention were enrolled in this prospective observational study. All patients underwent cardiovascular magnetic resonance (CMR) to define salvaged myocardium and infarct size within three to five days and at 3 months after acute MI. Patients were stratified according to apnoea-hypopnoea index (AHI) assessed by polysomnography at baseline into those with (AHI ≥ 15/h) and without (AHI < 15/h) SDB. Of the 56 patients included, 29 (52%) had SDB. The area at risk between both groups was similar (40 ± 12% vs. 40 ± 14%, P = 0.925). Patients with SDB had significantly less salvaged myocardium (myocardial salvage index 52% vs. 77%, P < 0.001), smaller reduction in infarct size (0.3% vs. 6.5%, P < 0.001) within 3 months after acute MI, a larger final infarct size (23% vs. 12%, P < 0.001), and a lower final left ventricular ejection fraction (48% vs. 54%, P = 0.023). In a multivariate analysis, including established risk factors for large MI, AHI was independently associated with less myocardial salvage and a larger infarct size 3 months after acute MI.
CONCLUSIONS: Sleep-disordered breathing was associated with less myocardial salvage and a smaller reduction in infarct size. These findings suggest a contribution of SDB to impaired healing of MI.

Entities:  

Keywords:  Heart failure; Magnetic resonance imaging; Myocardial infarction; Sleep apnoea

Mesh:

Year:  2013        PMID: 24164862     DOI: 10.1093/eurheartj/eht450

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  29 in total

1.  Evaluation of the association between sleep apnea and polyunsaturated fatty acids profiles in patients after percutaneous coronary intervention.

Authors:  Keisuke Nakabayashi; Kentaro Jujo; Katsumi Saito; Toshiaki Oka; Nobuhisa Hagiwara
Journal:  Heart Vessels       Date:  2017-06-19       Impact factor: 2.037

2.  Relationship between severity of obstructive sleep apnea and adverse cardiac outcomes in non-diabetic patients presenting with myocardial infarction.

Authors:  Liang-Ping Zhao; Kelvin Loh; Germaine Loo; See-Meng Khoo; Liang Shen; Chi-Hang Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-07       Impact factor: 2.503

Review 3.  The importance of sleep-disordered breathing in cardiovascular disease.

Authors:  Dominik Linz; Holger Woehrle; Thomas Bitter; Henrik Fox; Martin R Cowie; Michael Böhm; Olaf Oldenburg
Journal:  Clin Res Cardiol       Date:  2015-04-23       Impact factor: 5.460

4.  Cardiac Troponin Values in Patients With Acute Coronary Syndrome and Sleep Apnea: A Pilot Study.

Authors:  Alicia Sánchez-de-la-Torre; Xavier Soler; Ferran Barbé; Marina Florés; Alan Maisel; Atul Malhotra; Montserrat Rue; Sandra Bertran; Albina Aldomá; Fernando Worner; Joan Valls; Chi-Hang Lee; Cecilia Turino; Estefanía Galera; Jordi de Batlle; Manuel Sánchez-de-la-Torre
Journal:  Chest       Date:  2017-07-20       Impact factor: 9.410

5.  Treatment of OSA reduces the risk of repeat revascularization after percutaneous coronary intervention.

Authors:  Xiaofan Wu; Shuzheng Lv; Xiaohong Yu; Linyin Yao; Babak Mokhlesi; Yongxiang Wei
Journal:  Chest       Date:  2015-03       Impact factor: 9.410

Review 6.  Obstructive sleep apnoea and coronary artery disease.

Authors:  Swapna Mandal; Brian D Kent
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 7.  Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications.

Authors:  Elise Belaidi; Jessica Morand; Emmanuelle Gras; Jean-Louis Pépin; Diane Godin-Ribuot
Journal:  Pharmacol Ther       Date:  2016-08-02       Impact factor: 12.310

Review 8.  Prevalence of sleep-disordered breathing in acute coronary syndrome: a systemic review and meta-analysis.

Authors:  Zhuoshan Huang; Zhengda Zheng; Yanting Luo; Suhua Li; Jieming Zhu; Jinlai Liu
Journal:  Sleep Breath       Date:  2016-08-22       Impact factor: 2.816

9.  Sleep Disturbances in Patients With Coronary Heart Disease: A Systematic Review.

Authors:  Michael Tilling Madsen; Chenxi Huang; Graziella Zangger; Ann Dorthe Olsen Zwisler; Ismail Gögenur
Journal:  J Clin Sleep Med       Date:  2019-03-15       Impact factor: 4.062

10.  Sleep Apnea Evolution and Left Ventricular Recovery After Percutaneous Coronary Intervention for Myocardial Infarction.

Authors:  Li-Ling Tan; Jeanette Ting; Iswaree Balakrishnan; Aruni Seneviratna; Lingli Gong; Mark Y Chan; E Shyong Tai; A Mark Richards; Bee-Choo Tai; Lieng-Hsi Ling; Chi-Hang Lee
Journal:  J Clin Sleep Med       Date:  2018-10-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.